<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2709-7927</journal-id>
<journal-title><![CDATA[Acta Médica del Centro]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd centro]]></abbrev-journal-title>
<issn>2709-7927</issn>
<publisher>
<publisher-name><![CDATA[Hospital Provincial Clínico Quirúrgico Universitario Arnaldo Milián Castro]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2709-79272023000300423</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome metabólico en pacientes con diabetes mellitus tipo 2 mayores de 40 años]]></article-title>
<article-title xml:lang="en"><![CDATA[Metabolic syndrome in patients with type 2 diabetes mellitus older than 40 years of age]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Portal Martin]]></surname>
<given-names><![CDATA[Ana Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Pérez]]></surname>
<given-names><![CDATA[Luis Oscar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Junco Bringa]]></surname>
<given-names><![CDATA[Diosvany]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Villa Clara  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Provincial Clínico Quirúrgico Universitario &#8220;Arnaldo Milián Castro&#8221;  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2023</year>
</pub-date>
<volume>17</volume>
<numero>3</numero>
<fpage>423</fpage>
<lpage>438</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2709-79272023000300423&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2709-79272023000300423&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2709-79272023000300423&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  la diabetes mellitus tipo 2 se asocia con otras alteraciones metabólicas y no metabólicas, con el posible nexo patogénico común de la resistencia a la insulina y la progresión de la enfermedad cardiovascular aterosclerótica. A esta situación se la ha denominado síndrome metabólico.  Objetivo:  caracterizar a los pacientes con síndrome metabólico y diabetes mellitus tipo 2 mayores de 40 años.  Métodos:  estudio de desarrollo, descriptivo, de corte transversal. El universo estuvo comprendido por 289 pacientes con diagnóstico de diabetes mellitus tipo 2 y la muestra por 159 con tres o más criterios para establecer el diagnóstico de síndrome metabólico.  Resultados:  el diagnóstico de síndrome metabólico predominó para las mujeres con cuatro criterios (44,3%). La obesidad, el sedentarismo, la hipertensión arterial y la dislipidemia, como antecedentes patológicos familiares, fueron los factores de riesgo predominantes y 10 años de evolución (41,6%), con mayor porciento de criterios para el diagnóstico, lo que empeoró el control metabólico y aumentó el riesgo cardiovascular.  Conclusiones:  predominaron los pacientes diagnosticados con síndrome metabólico con tres y cuatro criterios en igual proporción. Los antecedentes familiares de hipertensión arterial, obesidad y sedentarismo fueron los más frecuentes, y la hipertensión arterial, la obesidad abdominal y la dislipidemia los aspectos clínicos y bioquímicos más relevantes. Prevalecieron los que tenían entre cinco y 10 años de evolución de la enfermedad, con tratamientos combinados de antidiabéticos orales e insulina y con un control aceptable. El incremento de los años de evolución de la diabetes y su mal control aumentan los criterios diagnósticos del síndrome metabólico, con alto y muy alto riesgo cardiovascular.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  type 2 diabetes mellitus is associated with other metabolic and non-metabolic disorders, with the possible common pathogenic link of insulin resistance and the progression of atherosclerotic cardiovascular disease. This situation has been denominated the metabolic syndrome.  Objective:  to characterize patients with metabolic syndrome and type 2 diabetes mellitus over 40 years of age.  Methods:  a descriptive, cross-sectional, developmental study, the universe consisted of 289 patients with a diagnosis of type 2 diabetes mellitus and the sample consisted of 159 patients with three or more criteria to establish the diagnosis of metabolic syndrome.  Results:  the diagnosis of metabolic syndrome predominated in women with four criteria (44.3%); obesity, sedentary lifestyle, arterial hypertension and dyslipidemia, as family pathological history, were the predominant risk factors and 10 years of evolution (41.6%), with the highest percentage of criteria for diagnosis, which worsened metabolic control and increased cardiovascular risk.  Conclusions:  patients diagnosed with metabolic syndrome with three and four criteria predominated in equal proportions. Family history of arterial hypertension, obesity and sedentary lifestyle were the most frequent, and arterial hypertension, abdominal obesity and dyslipidemia were the most relevant clinical and biochemical aspects. Those with between five and 10 years of evolution of the disease, with combined treatment of oral antidiabetics and insulin and with acceptable control prevailed. The increase in the number of years of evolution of diabetes and its poor control increase the diagnostic criteria for metabolic syndrome, with high and very high cardiovascular risk.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[síndrome metabólico]]></kwd>
<kwd lng="es"><![CDATA[riesgo cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[diabetes mellitus tipo 2]]></kwd>
<kwd lng="en"><![CDATA[metabolic syndrome]]></kwd>
<kwd lng="en"><![CDATA[cardiovascular risk]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus, type 2]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González Sarmiento]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pascual Calleja]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Laclaustra Gimeno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Casasnovas Lenguas]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico y diabetes mellitus]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2005</year>
<volume>5</volume>
<numero>D</numero>
<issue>D</issue>
<page-range>30d-7d</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo Hernández]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas González]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Almar Galiana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Romero Hernández]]></surname>
<given-names><![CDATA[EY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico, un problema de salud pública con diferentes definiciones y criterios]]></article-title>
<source><![CDATA[Rev Med UV]]></source>
<year>2017</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>7-24</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirode]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in the prevalence of metabolic syndrome in the United States, 2011-2016]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2020</year>
<volume>323</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2526-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCracken]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Monaghan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sreenivasan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology of the metabolic syndrome]]></article-title>
<source><![CDATA[Clin Dermatol]]></source>
<year>2018</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-20</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdés Ramos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bencosme Rodríguez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico y enfermedad cardiovascular en personas con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>2013</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>125-35</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piñeros-Garzón]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Hernández]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados al control glucémico y síndrome metabólico en pacientes con diabetes mellitus tipo 2. Villavicencio, Colombia]]></article-title>
<source><![CDATA[Univ Salud]]></source>
<year>2019</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>61-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero Sabournin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez Vega]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Folgueiras Pérez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia del síndrome metabólico en la población de dos consultorios del Policlínico &#8220;Primero de Enero&#8221;]]></article-title>
<source><![CDATA[Rev Cubana Med]]></source>
<year>2020</year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orozco Villaroel]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estilos de vida en pacientes con diabetes tipo II que acuden al centro materno infantil &#8220;Enrique Ponce Luque&#8221;, Babahoyo, 2019]]></article-title>
<source><![CDATA[Más Vita]]></source>
<year>2020</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>33-44</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barros Calderón]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa Cano]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez Coronel]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis del afrontamiento a la diabetes mellitus tipo II]]></article-title>
<source><![CDATA[UCT]]></source>
<year>2021</year>
<volume>110</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>191-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herranz Antolín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez de Frutos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Torralba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución clínica de una cohorte de pacientes con diabetes mellitus tipo 2 tras su valoración en endocrinología. Estudio a 26 semanas]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr]]></source>
<year>2018</year>
<volume>65</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>220-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antúnez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bettiol]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Depresión en pacientes con diabetes tipo 2 que acuden a una consulta externa de medicina interna]]></article-title>
<source><![CDATA[Acta Med Colomb]]></source>
<year>2016</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>102-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Ramírez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínico epidemiológico de la diabetes mellitus tipo 2 en pacientes hospitalizados. Mayarí, 2016]]></article-title>
<source><![CDATA[Rev Méd Electrón]]></source>
<year>2018</year>
<volume>40</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez Almaguer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Casado Méndez]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Santos Fonseca]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Almaguer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Ramírez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percepción de la calidad de vida en pacientes adultos mayores con diabetes mellitus tipo II]]></article-title>
<source><![CDATA[Medimay]]></source>
<year>2019</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>54-62</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivas Alpizar]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Zerquera Trujillo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Gutiérrez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vicente Sánchez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo práctico del paciente con diabetes mellitus en la Atención Primara de Salud]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2011</year>
<volume>1</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>229-50</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Control metabólico de pacientes con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Soc Peru Med Interna]]></source>
<year>2013</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>68-70</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gabetta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Amarilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rivelli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Guillén]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cantero Estigarribia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chaparro Báez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Control glucémico de pacientes diabéticos en dos Unidades de Salud Familiar, Paraguay, 2018. Estudio piloto]]></article-title>
<source><![CDATA[Rev Virtual Soc Parag Med Int]]></source>
<year>2019</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-30</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avalos García]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[López Ramón]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Morales García]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Priego Álvarez]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido Pérez]]></surname>
<given-names><![CDATA[SMG]]></given-names>
</name>
<name>
<surname><![CDATA[Cargill Foster]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad en el control de la diabetes mellitus en unidades de atención primaria de México. Un estudio desde la perspectiva de la familia de los pacientes]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2017</year>
<volume>49</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuevas Fernández]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez de Armas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cerdeña Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Andreu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Iglesias Girón]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[García Marrero]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mal control de la diabetes tipo 2 en un centro de salud de atención primaria: factores modificables y población diana]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2021</year>
<volume>53</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[IW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Need for intensive, early glycaemic control in patients with type 2 diabetes]]></article-title>
<source><![CDATA[Brit J Cardiol]]></source>
<year>2000</year>
<volume>7</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>625-31</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rascón-Pacheco]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Candia-Plata]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Icedo]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Romero Arredondo]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Brito-Zurita]]></surname>
<given-names><![CDATA[OR]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero-Romero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Codificación geométrica y análisis de conglomerados para evaluar el control metabólico de pacientes con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Panam Salud Pública]]></source>
<year>2010</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>276-82</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Orri]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lara Severino]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Zúñiga Juárez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas Celio]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Parra Pérez]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Roda Miranda]]></surname>
<given-names><![CDATA[OI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis por conglomerados para evaluar el control metabólico de pacientes diabéticos tipo 2]]></article-title>
<source><![CDATA[Nutr Clín Diet Hosp]]></source>
<year>2016</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>117-24</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eckel]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Grundy]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Zimmet]]></surname>
<given-names><![CDATA[PZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The metabolic syndrome]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2005</year>
<volume>365</volume>
<numero>9468</numero>
<issue>9468</issue>
<page-range>1415-28</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grundy]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Smith Jr]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Cleeman]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Kahn]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<collab>American Heart Association</collab>
<article-title xml:lang=""><![CDATA[Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management]]></article-title>
<source><![CDATA[Arterioscler Thromb Vasc Biol]]></source>
<year>2004</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e19-24</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kahn]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome: is it a syndrome? Does it matter?]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2007</year>
<volume>115</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1806-10</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdés Ramos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bencosme Rodríguez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las complicaciones macrovasculares y su relación con algunas variables clínicas y bioquímicas en diabéticos tipo 2]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>2010</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>256-68</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancheno Lazo]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Relación entre el índice cintura/estatura y el riesgo cardiovascular en una población de 30 a 64 años de edad que acude al centro de salud tipo b del Cantón Guano, provincia de Chimborazo, 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Riobamba ]]></publisher-loc>
<publisher-name><![CDATA[Escuela Superior Politécnica de Chimborazo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alegría Ezquerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castellano Vázquez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Alegría Barrero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2008</year>
<volume>61</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>752-64</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[BEK]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2002</year>
<volume>25</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1790-4</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solymoss]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Bourassa]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Campeau]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sniderman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marcil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lespérance]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2004</year>
<volume>93</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>159-64</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
